Farther Finance Advisors’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.7K Sell
179
-5
-3% -$603 ﹤0.01% 4236
2026
Q2
$24.5K Buy
184
+23
+14% +$2.6K ﹤0.01% 3818
2026
Q1
$18.5K Buy
161
+133
+475% +$15.7K ﹤0.01% 3715
2025
Q4
$3.78K Buy
28
+20
+250% +$2.18K ﹤0.01% 4444
2025
Q3
$679 Buy
+8
New +$490 ﹤0.01% 4466

Other funds holding ABVX

Farther Finance Advisors's ABVX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Abivax (ABVX) stake by 2.7% in Q3 2026, selling an estimated $603 and leaving 179 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4236.

Farther Finance Advisors first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $24.5K in Q2 2026. 13 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Farther Finance Advisors held 179 shares of Abivax worth $17.7K as of Q3 2026.
  • Farther Finance Advisors sold 5 Abivax shares in Q3 2026, an estimated $603.
  • Abivax made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4236 holding.
  • Farther Finance Advisors first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
  • Farther Finance Advisors's Abivax position peaked at $24.5K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.